Quantcast

Latest gastric cancer Stories

2012-09-05 23:04:23

New research study “Gastric Cancer - Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020” prepared by GlobalData has been recently published by Market Publishers Ltd. The report finds that the global gastric cancer drug market will experience robust growth over the next decade. London, UK (PRWEB) September 04, 2012 The global gastric cancer drug market will experience robust growth over the next decade, driven by the rapid uptake and market...

2012-07-16 10:23:14

A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality. Although the incidence of gastric cancer has decreased substantially in the western part of the world, the disease is still common in areas such as...

2011-07-21 07:00:02

(Ivanhoe Newswire) -- In the largest study of its kind, researchers say different populations of people need different therapies to get rid of H. pylori, which is the primary cause of gastric cancer. According to the International Agency for Research on Cancer, stomach cancer was the fourth most common cancer and the second-leading cause of cancer death in the world in 2008. About 72 percent of new cases occur in developing countries. The current study, which was conducted at seven sites...

2011-07-20 12:24:52

Largest study of its kind suggests different populations need different therapies to eradicate H. pylori, primary cause of gastric cancer Helicobacter pylori, the bacterium known to cause peptic ulcers, is also the primary cause of gastric cancer, which is a leading cancer killer globally. A large clinical trial at seven sites across Latin America has now found that a standard three-drug regimen for treating H. pylori is more effective, at least in the population studied, than either of two...

2011-05-18 13:57:15

No increase seen from moderate alcohol consumption The results from a very well-done meta-analysis support other data generated on the risk of alcohol consumption and gastric cancer "“ that is "“ that the risk may be real for heavy alcohol consumption but not for moderate intake. The type of gastric cancer relating to heavier alcohol intake in this study tended to be tumors involving the noncardia, but differences between the association with tumors of the gastric cardia were not...

2011-04-07 08:04:59

(Ivanhoe Newswire) -- A big beer belly isn't the only concern for heavy beer drinkers. People who drink a significant amount of beer and have a specific genetic variant in the cluster of three genes that metabolize alcohol have a significantly higher risk of developing non-cardiac gastric cancer, according to a new study. Study results also showed that the same risk is also elevated (but not as significantly) for heavy beer drinkers who do not have the variant. "This is a classic...

2011-04-04 19:40:39

Heavy beer drinkers who have a specific genetic variant in the cluster of three genes that metabolize alcohol are at significantly higher risk of developing non-cardia gastric cancer, according to research presented at the AACR 102nd Annual Meeting 2011, held here April 2-6. Study results also showed that the same risk is also elevated (but not as significantly) for heavy beer drinkers who do not have the variant, known as rs1230025, and for non-drinkers who have rs1230025 or rs283411. "This...

2011-04-04 12:00:00

QUEBEC CITY, April 4 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company")  today announced that two posters on its lead anticancer agent, perifosine, were presented at the 102(nd) annual meeting of the American Association for Cancer Research currently held at the Orange County Convention Center in Orlando, Florida. Poster #1965: Entitled, "Antitumor activity of novel Akt inhibitor, perifosine in gastric cell lines",Tae Soo Kim, Hyo Song Kim, Bo...

2011-03-25 08:00:00

CAMBRIDGE, Mass., March 25, 2011 /PRNewswire/ -- Mersana Therapeutics today announced the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001, a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line gastric cancer and second-/third-line non-small cell lung cancer. The study will be carried out in 10 clinical centers in the US. The Phase 1b follows the successful completion of a...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related